Application and Prognostic Analysis of Vacuum Sealing Drainage in the Incision Infection in Patients With Stage II-III Colorectal Cancer.

IF 1 4区医学 Q3 SURGERY

American Surgeon Pub Date : 2024-12-01 Epub Date: 2024-07-19 DOI:10.1177/00031348241265133

Bao Lin, Hongjian Zhang, Shijie Sun, Changqing Lin, Yuanlong Chi

{"title":"Application and Prognostic Analysis of Vacuum Sealing Drainage in the Incision Infection in Patients With Stage II-III Colorectal Cancer.","authors":"Bao Lin, Hongjian Zhang, Shijie Sun, Changqing Lin, Yuanlong Chi","doi":"10.1177/00031348241265133","DOIUrl":null,"url":null,"abstract":"Introduction: This study aims to explore the application value of vacuum sealing drainage (VSD) technology in the treatment of incision infection dehiscence after surgery in patients with stage II-III colorectal cancer and analyze its impact on prognosis.Methods: This retrospective study included patients who experienced incision infection dehiscence after surgery for colorectal cancer between February 2014 and August 2019. Clinical and pathological data, short-term outcomes, and long-term outcomes were compared between the traditional group and the VSD group.Results: A total of 97 patients were included in this study. There was no significant difference in clinical and pathological data between the traditional group and the VSD group (P > 0.05). The VSD group had fewer dressing changes, lower pain scores during dressing changes, and better granulation tissue growth grading than the traditional group, with statistical significance (P < 0.05). The VSD group started adjuvant chemotherapy earlier and had a higher proportion of ≥4 cycles of chemotherapy. The three-year overall survival rate in the VSD group was better than the traditional group, but the difference was not statistically significant (P > 0.05).Conclusion: The application of VSD technology can promote granulation tissue growth, accelerate incision healing, and facilitate patients to complete subsequent adjuvant chemotherapy. However, further verification of its long-term impact on prognosis requires longer-term follow-up results.","PeriodicalId":7782,"journal":{"name":"American Surgeon","volume":" ","pages":"3253-3261"},"PeriodicalIF":1.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00031348241265133","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This study aims to explore the application value of vacuum sealing drainage (VSD) technology in the treatment of incision infection dehiscence after surgery in patients with stage II-III colorectal cancer and analyze its impact on prognosis.

Methods: This retrospective study included patients who experienced incision infection dehiscence after surgery for colorectal cancer between February 2014 and August 2019. Clinical and pathological data, short-term outcomes, and long-term outcomes were compared between the traditional group and the VSD group.

Results: A total of 97 patients were included in this study. There was no significant difference in clinical and pathological data between the traditional group and the VSD group (P > 0.05). The VSD group had fewer dressing changes, lower pain scores during dressing changes, and better granulation tissue growth grading than the traditional group, with statistical significance (P < 0.05). The VSD group started adjuvant chemotherapy earlier and had a higher proportion of ≥4 cycles of chemotherapy. The three-year overall survival rate in the VSD group was better than the traditional group, but the difference was not statistically significant (P > 0.05).

Conclusion: The application of VSD technology can promote granulation tissue growth, accelerate incision healing, and facilitate patients to complete subsequent adjuvant chemotherapy. However, further verification of its long-term impact on prognosis requires longer-term follow-up results.

查看原文本刊更多论文

真空密封引流术在 II-III 期结直肠癌患者切口感染中的应用及预后分析

引言本研究旨在探讨真空密封引流（VSD）技术在治疗II-III期结直肠癌患者术后切口感染开裂中的应用价值，并分析其对预后的影响：这项回顾性研究纳入了2014年2月至2019年8月期间结直肠癌术后发生切口感染开裂的患者。比较了传统组和 VSD 组的临床和病理数据、短期疗效和长期疗效：结果：本研究共纳入97名患者。传统组和 VSD 组的临床和病理数据无明显差异（P>0.05）。与传统组相比，VSD 组换药次数少，换药时疼痛评分低，肉芽组织生长分级更好，差异有统计学意义（P < 0.05）。VSD组开始辅助化疗的时间更早，化疗≥4个周期的比例更高。VSD组的三年总生存率优于传统组，但差异无统计学意义（P > 0.05）：结论：VSD技术的应用可促进肉芽组织生长，加速切口愈合，有利于患者完成后续辅助化疗。结论：VSD 技术的应用可促进肉芽组织生长，加快切口愈合，有利于患者完成后续辅助化疗，但其对预后的长期影响还需要更长期的随访结果来进一步验证。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Surgeon 医学-外科

CiteScore

1.40

自引率

0.00%

发文量

623

期刊介绍： The American Surgeon is a monthly peer-reviewed publication published by the Southeastern Surgical Congress. Its area of concentration is clinical general surgery, as defined by the content areas of the American Board of Surgery: alimentary tract (including bariatric surgery), abdomen and its contents, breast, skin and soft tissue, endocrine system, solid organ transplantation, pediatric surgery, surgical critical care, surgical oncology (including head and neck surgery), trauma and emergency surgery, and vascular surgery.